Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback